Article Name Interaction
DHL’s new €10M pharmaceutical hub and expanded cold-chain network reinforce Singapore’s position as Asia Pacific’s life sciences and healthcare logistics powerhouse.
01st September, 2025
Mahesh Yermal, Head of Marketing, Vision Care (Consumer and Pharma), Alcon, shares how India became the launchpad for the company’s next-generation lens technology and its role in shaping the future of eye health.
26th August, 2025
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine.
13th August, 2025
Dr Ashton Harper, Global Medical Affairs Lead for Neurosciences at Roche Diagnostics, discusses how the CE-marked blood test enhances early detection, reduces invasive diagnostics, and aligns with the advent of disease-modifying therapies.
06th August, 2025
Sandeep Brar, Vice President of Clinical and Regulatory at Medtronic, shares insights on the scientific rationale, catheter design, and the future of multi-organ denervation in managing hypertension.
04th August, 2025
In conversation with MedTech Spectrum, Mr. Wong Yau Chung, Group CEO of Advanced MedTech Holdings, shares how the company is advancing kidney stone care, laser technologies, and digital platforms to address emerging urological challenges.
04th August, 2025
Dr. Truong Van Tri discusses Vietnam’s first robot-assisted SEEG procedure in a 9-year-old with drug-resistant epilepsy—highlighting precision innovation, local expertise, and a national vision for epilepsy care.
04th August, 2025
The NMPA approval of the ZEISS CLARUS 700 represents a major leap forward in ultra-widefield retinal imaging, offering high-resolution, true color visualization to support early detection and management of complex eye diseases across China.
21st July, 2025
The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY.
17th July, 2025
The CE Mark approval of the VitalFlow™ ECMO System marks a significant advancement in extracorporeal life support, delivering enhanced precision and control for managing critically ill cardiac and respiratory patients.
15th July, 2025
World-first deployment of AI-powered laser tech enhances medication safety in high-risk hospital settings
10th July, 2025
Highlighting key cybersecurity challenges and readiness gaps across the evolving medical device ecosystem.
07th July, 2025
CE Mark Approval Advances Precision Thrombectomy with Vessel-Conforming Design for Improved Stroke Outcomes Across Europe
02nd July, 2025
Next-gen GLP-1 therapies and real-time biosensors are redefining metabolic care—delivering effective weight loss while preserving muscle mass, and enabling more personalized, outcome-focused treatment.
01st July, 2025
New app rollout enhances insulin automation and real-time glucose monitoring through seamless smartphone control.
25th June, 2025
World Economic Forum recognizes INBRAIN for its groundbreaking graphene-based brain-computer interface platform aimed at treating neurological disorders with unmatched precision.
25th June, 2025
The first-in-human use of the Sola™ Coronary Laser IVL System marks a breakthrough in coronary calcium modification, providing physicians with a novel level of precision and control in treating complex calcified lesions.
20th June, 2025
The launch of Ruby® XL represents a breakthrough in vascular embolization, offering physicians unprecedented flexibility and efficiency for complex case management.
17th June, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer